Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

129.22 +9.57 (+8.00%)
Streaming Delayed Price Updated: 2:39 PM EDT, Jul 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,551,688
Open 126.00
Bid (Size) 128.96 (1)
Ask (Size) 129.50 (2)
Prev. Close 119.65
Today's Range 124.00 - 132.24
52wk Range 102.97 - 182.52
Shares Outstanding 55,679,964
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Repligen (RGEN) Stock Is Up Today
Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) jumped 7.8% in the morning session after the company reported strong second-quarter 2025 financial results and raised its... 
Via StockStory
Topics Artificial Intelligence Lawsuit
Repligen Corp (NASDAQ:RGEN) Q2 2025 Earnings: Revenue Beat Offsets EPS Miss as Stock Rises in Pre-Market
Repligen Corp's Q2 2025 earnings show revenue beat estimates at $182.4M, but EPS missed at $0.37. Stock rose 2.65% pre-market amid strong order growth. 
Via Chartmill

Performance

YTD
-9.7%
-9.7%
1 Month
+3.9%
+3.9%
3 Month
-10.0%
-10.0%
6 Month
-23.1%
-23.1%
1 Year
-6.4%
-6.4%

More News

Read More
Repligen’s (NASDAQ:RGEN) Q2 Sales Top Estimates, Full-Year Sales Guidance is Optimistic
Via StockStory
Earnings Scheduled For July 29, 2025
Via Benzinga
Earnings Scheduled For April 29, 2025
Via Benzinga
Repligen (RGEN) Reports Q2: Everything You Need To Know Ahead Of Earnings
Via StockStory
Forecasting The Future: 6 Analyst Projections For Repligen
Via Benzinga
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know
Via StockStory
Topics Lawsuit
1 Healthcare Stock to Target This Week and 2 to Be Wary Of
Via StockStory
Topics Stocks
What Analysts Are Saying About Repligen Stock
Via Benzinga
Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
1 Unprofitable Stock for Long-Term Investors and 2 to Ignore
Via StockStory
Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks
Via StockStory
Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers
Via StockStory
3 of Wall Street’s Favorite Stocks in Hot Water
Via StockStory
Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know
Via StockStory
Topics Government Stocks World Trade
1 High-Flying Stock with Exciting Potential and 2 to Keep Off Your Radar
Via StockStory
Deep Dive Into Repligen Stock: Analyst Perspectives (8 Ratings)
Via Benzinga
RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty
Via StockStory
Topics World Trade
Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations
Via StockStory
Topics World Trade
Repligen (RGEN) Q1 Earnings: What To Expect
Via StockStory
Topics World Trade
3 Healthcare Stocks That Concern Us
Via StockStory
Topics Stocks
Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings?
Via StockStory
Topics Stocks
Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks
Via StockStory
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers
Via StockStory

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 129.22
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 07/29/25 02:39 PM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 7.19B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.